Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation

NCT: NCT06429748 · ACTIVE_NOT_RECRUITING

NCT IDNCT06429748
StatusACTIVE_NOT_RECRUITING
Start Date2024-05-15
Completion2027-12-30
SponsorNeuronetics (OTHER)
First posted
Last updated

Brief Summary

A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.

Frequently Asked Questions

What is Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation?

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation is a clinical trial registered under NCT06429748. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06429748?

The current status of NCT06429748 (Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation) is: ACTIVE_NOT_RECRUITING.

When did Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation start?

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation started on 2024-05-15.

Related Devices

K160703NeuroStar TMS Therapy SystemNeuronetics, Inc. K161519NeuroStar TMS Therapy SystemNeuronetics, Inc. K201158NeuroStar Advanced TherapyNeuronetics, Inc. K212289NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStarNeuronetics, Inc. K213543NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar, NeuroStar Advanced Therapy for Mental HealthNeuronetics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑